Related Experiment Video
Updated: Oct 26, 2025
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization
Chao Dai1, Jonathan P Rennhack1, Taylor E Arnoff2
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Abstract:
Metastasis is a complex and poorly understood process. In pancreatic cancer, loss of the transforming growth factor (TGF)-β/BMP effector SMAD4 is correlated with changes in altered histopathological transitions, metastatic disease, and poor prognosis. In this study, we use isogenic cancer cell lines to identify SMAD4 regulated genes that contribute to the development of metastatic colonization. We perform an in vivo screen identifying FOSL1 as both a SMAD4 target and sufficient to drive colonization to the lung. The targeting of these genes early in treatment may provide a therapeutic benefit.
Insights
Loss of SMAD4 in pancreatic cancer promotes metastasis. Researchers identified FOSL1 as a key gene driving lung colonization, suggesting early therapeutic targeting may improve outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Metastasis is a complex process in cancer progression.
- Loss of SMAD4 in pancreatic cancer correlates with poor prognosis and metastasis.
- Understanding genes regulated by SMAD4 is crucial for identifying metastatic drivers.
Purpose of the Study:
- To identify genes regulated by SMAD4 that contribute to metastatic colonization in pancreatic cancer.
- To investigate the role of SMAD4-regulated genes in driving cancer spread.
Main Methods:
- Utilized isogenic cancer cell lines for precise genetic manipulation.
- Performed an in vivo screen to identify genes involved in metastasis.
- Analyzed SMAD4 target genes and their functional role in colonization.
Main Results:
- Identified FOSL1 as a direct target gene of SMAD4.
- Demonstrated that FOSL1 is sufficient to drive lung colonization in vivo.
- Correlated SMAD4 loss with increased metastatic potential.
Conclusions:
- FOSL1 is a critical mediator of SMAD4-dependent metastatic colonization in pancreatic cancer.
- Targeting SMAD4-regulated genes like FOSL1 early in treatment could offer therapeutic benefits.
- Further research into SMAD4-regulated pathways may reveal novel anti-metastatic strategies.
